| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |